Search Results 1081-1090 of 15445 for alt

1. A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination with Other Treatments in Subjects with Multiple Myeloma - Mayo Clinic

   Serum glutamic oxaloacetic transaminase (SGOT)/aspartate aminotransferase (AST) or serum glutamic pyruvic transaminase (SGPT)/alanine aminotransferase (ALT) ≥ ...

2. Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids - Mayo Clinic

   Inability to give informed consent. Currently taking Omega3 FFA as prescription; Anti-coagulant therapy (Plavix, Warfarin, Coumadin); AST or ALT level > three ...

3. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   Serum AST or ALT > 2.0 × upper limit of normal (ULN);; Total WBC count < 2500/µL;; Estimated glomerular filtration rate (eGFR) by simplified 4-variable ...

4. Validation of Cognitive Tests in Elderly Cirrhotic Patients - Mayo Clinic

   ... ALT ok), kidney (CKD > stage II), heart (any uncontrolled CAD, CHF, AFib and other serious arrhythmias), respiratory (COPD, IPF), endocrine (DM if last ...

5. A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled By Second Generation H1-antihistamines - Mayo Clinic

   ... (ALT) levels more than 1.5x ULN or International Normalized Ratio (INR) \> 1.5 at screening. Note: Other protocol defined Inclusion/Exclusion Criteria may ...

6. Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis - Mayo Clinic

   ... (ALT) =< 3x upper limit of normal (ULN) (except if secondary to hepatic involvement) (within 28 days prior to registration) - STEP 1: Alkaline phosphatase ...

7. A Study of the Safety, Tolerability and Effectiveness of Eleclazine on Shortening the QT Interval in Adults with Long QT-3 Syndrome - Mayo Clinic

   Abnormal liver function tests at screening, defined as alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 2 x upper limit of normal (ULN), or ...

8. A Study to Evaluate a Standard-dose and High- dose Regimen of Encorafenib + Binimetinib in Patients with BRAFV600-mutant Melanoma Brain Metastasis - Mayo Clinic

   AST and ALT ≤ 2.5 × ULN; in patients with liver metastases ≤ 5 × ULN;; Total bilirubin ≤ 1.5 × ULN. Note: Patients with documented Gilbert syndrome or ...

9. Clinical Trials - The SHUNT-V Study for Varices

   Abnormal liver enzymes (AST, ALT, or alkaline phosphatase), or, abnormal direct bilirubin, albumin, or INR (liver-related) of greater than 6 months duration.

10. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

    aminotransferase (ALT) =< 3.0 x ULN - ELIGIBILITY CRITERIA (STEP 1): Patients with known history or current symptoms of cardiac disease, or history of ...